{{Enzyme
|celltype=Ubiquitous, highly expressed
|celltype_source=GTEX
|celltype_source_key=ENSG00000101901
|description=Attach beta 4 GlcNAc to GlcNAc.
|disease=ALG13-CDG;Epileptic encephalopathy, early infantile, 36
|disease_source=HPO
|disease_source_key=79868
|genename=ALG13
|iscdg=true
|ortholog=Alg13
|phenotype=Abnormal bleeding;Abnormal lateral ventricle morphology;Abnormal pyramidal sign;Abnormality of brain morphology;Abnormality of extrapyramidal motor function;Adducted thumb;Anteverted nares;Atonic seizure;Autism;Cerebral atrophy;Clumsiness;Coarse facial features;Cognitive impairment;Decreased body weight;Delayed CNS myelination;Delayed speech and language development;Feeding difficulties;Flexion contracture;Generalized hypotonia;Global brain atrophy;Global developmental delay;Hepatomegaly;Horizontal nystagmus;Hydrocephalus;Hypertelorism;Hypotonia;Hypsarrhythmia;Infantile onset;Infantile spasms;Intellectual disability, severe;Long philtrum;Low-set ears;Macrocephaly;Microcephaly;Microretrognathia;Myoclonic seizure;Nystagmus;Optic atrophy;Poor head control;Prolonged partial thromboplastin time;Recurrent infections;Reduced eye contact;Scoliosis;Seizure;Self-mutilation;Short chin;Sleep disturbance;Small hand;Tonic seizure;Type I transferrin isoform profile;X-linked inheritance
|phenotype_source=HPO
|phenotype_source_key=79868
|species=Human
|tissue=Ubiquitous, highly expressed
|tissue_source=GTEX
|tissue_source_key=ENSG00000101901
|uniprot=Q9NP73
}}
